Wednesday, February 10, 2010, 3:02PM AEST - The Australian Stockmarket closes in 1 hour and 3 minutes.
To create a watchlist or portfolio of shares, Register

Teva Pharmaceutical Industries Limited (TEVA)

 8:00AM AEST: 57.10 USD  Up 0.18 (0.32%)  
 MORE ON TEVA 
Quotes
HereSummary
Charts
Technical Analysis
News & Info
Company
Analyst Coverage
Ownership
Financials
 Teva Pharmaceutical Industries (NasdaqNM:TEVA) Delayed quote dataEdit
Last Trade:57.10 USD
Trade Time: 8:00AM AEST
Change:Up 0.18 (0.32%)
Prev Close:56.92
Open:57.31
Bid:56.14 x 100
Ask:57.97 x 100
1y Target Est:65.25
Day's Range:56.72 - 57.59
52wk Range:42.00 - 59.62
Volume:4,539,807
Avg Vol (3m):4,959,040
Market Cap:50.31B
P/E (ttm):52.24
EPS (ttm):1.09
Div & Yield:0.61 (1.06%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
 Add TEVA to Portfolio   Download Data

 HEADLINES 
•[video] Stock Wrap: The Real Story, February 9
at TheStreet.com (Wed 8:52AM)
•AstraZeneca Goes to the Well One Last Time
at Minyanville.com (Wed 4:50AM)
•The New Danger for Foreign Investors?
at Motley Fool (Wed 3:22AM)
•Five Growth Stocks With a Margin of Safety
at TheStreet.com (Tue 9:00PM)
•Teva gets Nordic and Baltic rights for MS drug from Active Biotech
at bizjournals.com (Tue 4:05AM)
•Teva, Active extend pact on oral MS therapy
at MarketWatch (Tue 2:07AM)
•Teva Acquires Marketing Rights for Oral Laquinimod in the Nordic and Baltic Regions
Business Wire (Tue 12:30AM)
•Teva Settles Lawsuits for $315 Million
at Fox Business (Sat, Feb 6)
•[$$] Teva Reaches Preliminary Settlement In Drug Pricing Suit
at The Wall Street Journal Online (Sat, Feb 6)
•Emerging-Market ETFs Still Have Steam
at TheStreet.com (Sat, Feb 6)
More Headlines for TEVA...
 ANALYST 
EPS Est (next year) (Dec-09) :3.37
EPS Est (in 2 years) (Dec-10) :4.52
Avg Rec (current)*:1.6
PEG Ratio:1.15
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
Teva Pharmaceutical Industries Limited engages in the development, production, and sale of a range of generic and branded pharmaceuticals, biogenerics, and active pharmaceutical ingredients (APIs) worldwide.

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
•Latest News•7 Indices